Dr. Reddy's Laboratories Limited (RDY)
NYSE: RDY · Real-Time Price · USD
15.50
-0.09 (-0.58%)
At close: Jun 25, 2025, 4:00 PM
15.37
-0.13 (-0.81%)
After-hours: Jun 25, 2025, 7:38 PM EDT
Dr. Reddy's Laboratories Market Cap
Dr. Reddy's Laboratories has a market cap or net worth of $12.97 billion as of June 25, 2025. Its market cap has increased by 10.67% in one year.
Market Cap
12.97B
Enterprise Value
12.88B
1-Year Change
10.67%
Ranking
Category
Stock Price
$15.50
Market Cap Chart
Since April 11, 2001, Dr. Reddy's Laboratories's market cap has increased from $839.80M to $12.97B, an increase of 1,443.88%. That is a compound annual growth rate of 11.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 24, 2025 | 13.01B | -1.22% |
| Dec 31, 2024 | 13.17B | 13.66% |
| Dec 29, 2023 | 11.59B | 34.54% |
| Dec 30, 2022 | 8.61B | -20.82% |
| Dec 31, 2021 | 10.88B | -8.18% |
| Dec 31, 2020 | 11.85B | 75.79% |
| Dec 31, 2019 | 6.74B | 7.74% |
| Dec 31, 2018 | 6.25B | 0.47% |
| Dec 29, 2017 | 6.23B | -19.41% |
| Dec 30, 2016 | 7.73B | -2.05% |
| Dec 31, 2015 | 7.89B | -8.10% |
| Dec 31, 2014 | 8.58B | 23.16% |
| Dec 31, 2013 | 6.97B | 23.45% |
| Dec 31, 2012 | 5.64B | 13.32% |
| Dec 30, 2011 | 4.98B | -20.18% |
| Dec 31, 2010 | 6.24B | 53.01% |
| Dec 31, 2009 | 4.08B | 147.47% |
| Dec 31, 2008 | 1.65B | -45.95% |
| Dec 31, 2007 | 3.05B | 9.23% |
| Dec 29, 2006 | 2.79B | 68.91% |
| Dec 30, 2005 | 1.65B | 8.92% |
| Dec 31, 2004 | 1.52B | -37.34% |
| Dec 31, 2003 | 2.42B | 50.67% |
| Dec 31, 2002 | 1.61B | 2.01% |
| Dec 31, 2001 | 1.58B | 87.63% |
View and export this data all the way back to 2001.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 688.64B |
| Johnson & Johnson | 362.55B |
| Novo Nordisk | 326.28B |
| AbbVie | 323.30B |
| UnitedHealth Group | 270.55B |
| Abbott Laboratories | 230.46B |
| Novartis AG | 227.54B |
| AstraZeneca | 217.06B |